Navigating the Next Wave of Innovation in eCOA
In this episode, Suvoda brings together an expert panel to explore the evolving landscape of eCOA. Featuring Andres Escallon, Vice President of eCOA Solutions Strategy; Jill Platko, Vice President of Scientific Services; and Ian Jennings, Executive Vice President of Enterprise eCOA Sales. The conversation dives into simplifying clinical trial processes and the importance of building trust through strong, evidence-based practices. While innovation is key, the panel emphasizes that maintaining focus on the fundamentals will shape the future of effective, patient-centered clinical research.
You will learn:
- What Makes a Strong eCOA Process – Get insight into the essential elements of a reliable, scalable eCOA framework—built on trust, quality, and evidence-based design.
- Why Simplicity is a Strategic Advantage – Discover how simplifying trial design and execution leads to better outcomes for sponsors, sites, and patients.
- Why Data Integrity Matters More Than Volume – Learn why researchers are shifting focus toward collecting cleaner, more meaningful data rather than aiming for sheer quantity.
Meet the Guests
Ian Jennings
Executive Vice President, Enterprise eCOA Sales
Ian Jennings, Executive Vice President, Enterprise eCOA Sales at Suvoda, has spent his entire 35-year career in commercial roles within the Life Science sector, focused on clinical trial solutions spanning eCOA, eConsent, IRT, EDC, CTMS, Medical Imaging, Patient Recruitment/Engagement, and Digital Patient solutions. Prior to joining Suvoda, Ian held leadership roles at Signant Health, ERT (now Clario), Exco InTouch, Parexel Informatics, ClinPhone, and PHT Corporation. Ian believes strongly in the power of people and teams to collaborate with a single focus to meet customer expectations. He is passionate about patient-facing technologies that enable clinical trial participants to better engage in their trial journey, ultimately leading to better outcomes for all stakeholders. Ian holds a BSc with Honours in Applied Chemistry from Sheffield Hallam University, UK.
Andres Escallon
Vice President, eCOA Solutions Strategy
Andrés Escallón, the Vice President of eCOA Solutions Strategy at Suvoda, boasts over 18 years of expertise in the eCOA industry. With roots at PHT Corporation and subsequent leadership roles at ERT, Andrés has been a driving force in eCOA project and program management. Recognized as an eCOA Subject Matter Expert, he joined Suvoda in 2021 as the Vice President of eCOA Practice, building a team and seamlessly integrating eCOA functions into Suvoda’s successful IRT delivery framework. In his current role, Andrés guides Suvoda’s eCOA product and commercial strategy, provides consultative support to industry stakeholders, and serves as the face of the eCOA product, showcasing his strategic leadership in the dynamic eCOA landscape.
Jill Platko
Vice President, Scientific Services
A recognized industry thought leader, Jill brings over 30 years of scientific and 15 years eCOA experience to Suvoda as Vice President of Scientific Services. Prior to Suvoda, Jill led the development of the Scientific Advisory practice at Signant Health. While there, she advised and consulted on the design of novel ePROs for epilepsy, migraine, Parkinson’s, and diabetes studies. Jill also has held leadership positions with Covance and PHT Corporation. Her expertise is often sought for publications, industry consortiums, and speaking engagements. Jill earned a bachelor’s degree in biology and mathematics from SUNY, and a doctorate in genetics and development from Cornell University.
About Suvoda
Suvoda is a global clinical trial technology company working to transform patients’ experience in complex, life-sustaining studies in therapeutic areas like oncology, central nervous system (CNS), and rare diseases. Founded in 2013 by experts in eClinical systems, Suvoda empowers sponsors, CROs, sites, and patients to manage even the most urgent moments in the most urgent trials through advanced software solutions delivered on a single platform. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company’s Net Promoter Score (NPS) consistently exceeds the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 1,500 trials across more than 85 countries. To learn more, visit suvoda.com.
